A detailed history of First Trust Advisors LP transactions in Care Dx, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 26,940 shares of CDNA stock, worth $568,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,940
Holding current value
$568,164
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$14.41 - $33.99 $388,205 - $915,690
26,940 New
26,940 $841,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $60,546 - $99,490
3,770 Added 39.94%
13,210 $225,000
Q2 2022

Aug 12, 2022

BUY
$20.49 - $39.72 $193,425 - $374,956
9,440 New
9,440 $203,000
Q1 2022

May 13, 2022

SELL
$28.19 - $46.6 $1.02 Million - $1.69 Million
-36,253 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$41.2 - $73.6 $2.06 Million - $3.68 Million
-50,062 Reduced 58.0%
36,253 $1.65 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $829,223 - $1.29 Million
14,019 Added 19.39%
86,315 $5.47 Million
Q2 2021

Aug 16, 2021

BUY
$63.02 - $95.11 $22,309 - $33,668
354 Added 0.49%
72,296 $6.62 Million
Q1 2021

May 14, 2021

BUY
$57.62 - $95.6 $694,263 - $1.15 Million
12,049 Added 20.12%
71,942 $4.9 Million
Q4 2020

Feb 02, 2021

BUY
$41.43 - $77.09 $83,688 - $155,721
2,020 Added 3.49%
59,893 $4.34 Million
Q3 2020

Nov 05, 2020

SELL
$30.88 - $37.94 $241,605 - $296,842
-7,824 Reduced 11.91%
57,873 $2.2 Million
Q2 2020

Jul 22, 2020

BUY
$18.95 - $35.43 $1.24 Million - $2.33 Million
65,697 New
65,697 $2.33 Million
Q4 2019

Feb 03, 2020

SELL
$19.24 - $28.41 $2 Million - $2.96 Million
-104,191 Closed
0 $0
Q3 2019

Nov 04, 2019

BUY
$20.03 - $40.08 $65,678 - $131,422
3,279 Added 3.25%
104,191 $2.36 Million
Q2 2019

Jul 30, 2019

BUY
$25.78 - $39.77 $2.6 Million - $4.01 Million
100,912 New
100,912 $3.63 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.13B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.